Contributions
2,121 recent contributions in Hansard
HANSARDIntegrated Care Boards: BudgetsThe noble Lord raises a good point about data. Indeed, one of the pieces of work we are doing with ICBs on how they commission services is requiring better data and data analysis.…17 Jun 2026HANSARDIntegrated Care Boards: BudgetsNo ICB should be taking that line. My noble friend is aware that in line with the 10-year plan, NHS England has asked integrated care boards to reduce their running costs. I…17 Jun 2026HANSARDIntegrated Care Boards: BudgetsTo develop further the reply I gave to my noble friend, ICBs have been asked to reduce their running cost allowance to a cap of £19.40 per head of weighted population for the…17 Jun 2026HANSARDIntegrated Care Boards: BudgetsMy Lords, integrated care boards are responsible for commissioning health services to meet local need. We do not intend to mandate a statutory minimum ring-fence for…17 Jun 2026HANSARDIntegrated Care Boards: BudgetsI understand why the noble Baroness is asking that question. I cannot confirm that that is the case, but I will gladly raise that point with my colleague the Minister for Care.17 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATI do not have the specific figures, but if I can access them, I would be happy to have noble Baroness receive them. It is important to step back here. As mentioned by the noble…16 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATAgain, I appreciate the invitation to enter into conversations about VAT more widely, which I will resist. Certainly, HMRC is aware of its role. We are trying to find the right…16 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATI am sure that the noble Lord would not want me to be quoted as suggesting that VAT should be charged on chocolates given free in shops, so I will not. The way in which VAT is…16 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATIndeed, we will. I can tell the noble Baroness how important speeding up access to medicines is. That is why, in April, we introduced the joint MHRA-NICE pathway for medicines,…16 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATIt is important to say, first, that this is not a new policy. There is recognition that while early access and compassionate use programmes are crucial, they are voluntary for…16 Jun 2026HANSARDCompassionate Use Medicine Schemes: VATCancer charities are important in this area, and we are certainly engaging with them; they are very invested partners. I understand why people are concerned. This is not instead…16 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentIn all cases in our development of the NHS app, which is the front door to the NHS and has already made tremendous steps forward in terms of access, we already build in provision…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentThe noble Baroness is quite right to talk about acceleration of clinical trials; as she and your Lordships’ House will be aware, that is exactly what we are doing. Not least, our…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentIndeed, I am pleased to give my noble friend that assurance, which is at the core of the national cancer plan. It is worth saying that many rare and less common cancers, including…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentMy Lords, improving diagnosis and treatment for rare cancer patients is a priority for this Government through the national cancer plan. The department is exploring procurement…15 Jun 2026HANSARDMental Health Conditions: DiagnosesMy Lords, I congratulate the noble Baroness, Lady Maclean, on securing this timely and highly relevant debate. I thank all noble Lords for their contributions. There is not…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentSuch considerations are always made, as the noble Lord is aware, when we make plans in respect of where taxation applies—I know there was an Urgent Question in the House of…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentI recognise what the noble Lord says about bottlenecks. That is why the national cancer plan is quite clear about the changes we will see. I should say, to the point in this…15 Jun 2026HANSARDRare Cancers: Diagnosis and TreatmentIt is key that we continue our commitment to speeding up research and clinical trials. We have already cut unnecessary bureaucracy, standardised processes and freed up workforce…15 Jun 2026HANSARDNew Autism Strategy (Autism Act 2009 Committee Report)My Lords, I start by thanking the noble Baroness, Lady Rock, for leading this important debate and, as many noble Lords have said, for chairing a committee that was very thorough…10 Jun 2026